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Abstract
Background:  Alzheimer's disease (AD) is a progressive, neurodegenerative disease mostly
affecting the basal forebrain, cortex and hippocampus whereas the cerebellum is relatively spared.
The reason behind this region-specific brain damage in AD is not well understood. Here, we report
our data suggesting "differential free fatty acid metabolism in the different brain areas" as a
potentially important factor in causing the region-specific damage observed in AD brain.
Findings: The astroglia from two different rat brain regions, cortex (region affected in AD) and
cerebellum (unaffected region), were treated with 0.2 mM of palmitic acid. The conditioned media
were then transferred to the cortical neurons to study the possible effects on the two main, AD-
associated protein abnormalities, viz. BACE1 upregulation and hyperphosphorylation of tau. The
conditioned media from palmitic-acid treated cortical astroglia, but not the cerebellar astroglia,
significantly elevated levels of phosphorylated tau and BACE1 in cortical neurons as compared to
controls (47 ± 7% and 45 ± 4%, respectively).
Conclusion: The present data provide an experimental explanation for the region-specific damage
observed in AD brain; higher fatty acid-metabolizing capacity of cortical astroglia as compared to
cerebellar astroglia, may play a causal role in increasing vulnerability of cortex in AD, while sparing
cerebellum.
Findings
Alzheimer's disease (AD) is a progressive neurodegenera-
tive disease, which affects basal forebrain, cortex and hip-
pocampus, while cerebellum is relatively spared [1]. AD
brain is characterized by extracellular deposits of amyloid
beta (Aβ) protein and intracellular accumulation of neu-
rofibrillary tangles [1]. Aβ protein is derived from the pro-
teolysis of β-amyloid precursor protein (APP) by β-
secretase (BACE1) and γ-secretase, BACE1 step being the
rate-limiting step [2]. The aggregation of Aβ leads to the
formation of senile plaques, a characteristic feature of AD
[1]. Aβ aggregates exert toxicity to nerve cells and thus play
a central role in AD-associated neurodegeneration [1].
Neurofibrillary tangles, the other major characteristic of
AD pathology, are composed of paired helical filaments
of microtubule-associated tau protein, which is hyper-
phosphorylated in AD [3]. The hyperphosphorylation of
tau leads to the disruption of the cytoskeleton of neurons
and their degeneration, thus playing an important role in
AD pathology [1].
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Epidemiological studies implicate that high fat diet con-
fers a significant risk for development of AD and the
degree of saturation of fatty acids is critical in determining
the risk for AD [4]. These studies are further supported by
various animal studies where mice fed high-fat-high cho-
lesterol diet developed AD-like pathophysiological
changes in their brain [5,6]. Furthermore, various vascular
diseases such as diabetes mellitus, hypertension and obes-
ity, which are characterized by increased levels of satu-
rated free fatty acids (FFAs), pose a significant risk for
developing AD [7-9]. Also, traumatic brain injury is an
independent risk factor for AD [10], and is characterized
by elevated levels of saturated fatty acids in the brain [11],
with palmitic acid increasing from ~60 to 180 μM and
stearic acid from ~50 to 350 μM [12]. Finally, apolipopro-
tein E4 (ApoE4) is an important genetic risk factor for AD
and its risk may be further increased by diets rich in satu-
rated fats [13].
Despite these data suggesting causal involvement of satu-
rated fatty acids in AD pathogenesis, their potential role in
causing the region-specific damage associated with AD
pathology is not well studied. In the present study, we
report our data suggesting "differential free fatty acid
(FFA) metabolism in the different brain areas" as a poten-
tial causal factor behind the region-specific damage
observed in AD.
Methods
Isolation and culture of neurons and astroglia from rat 
cortex
Primary cortical neurons were isolated from one-day-old
Sprague-Dawley rat pups and cultured according to the
published methods as described by Chandler et al. [14].
The cells were plated on poly-l-lysine-coated, six-well
plates at the concentration of 2 × 106 cells per well in fresh
cortical medium [Dulbecco's Modified Eagle's Medium
(DMEM, from Invitrogen, CA, USA) supplemented with
10% horse serum (Sigma, MO, USA), 25 mM glucose, 10
mM HEPES (Sigma), 2 mM glutamine (BioSource Inter-
national, CA, USA), 100 IU/ml penicillin, and 0.1 mg/ml
streptomycine]. To obtain pure neuronal cell cultures, the
medium was replaced with the cortical medium supple-
mented with 5 μM cytosine-β-arabinofuranoside (Arac,
from Calbiochem, CA) after 3 days of incubation (37°C,
5% CO2). After 2 days, the neuronal culture was switched
back to cortical medium without Arac. The experiments
were performed on 6- to 7-day-old neuronal cells. To
obtain primary cultures of cortical astroglia, the cortical
cells from one-day-old Sprague-Dawley rat pups were cul-
tured in DMEM/Ham's F12 medium (1:1), 10% fetal
bovine serum (Biomeda, CA, USA), 100 IU/ml penicillin,
and 0.1 mg/ml streptomycine [15]. The cells were plated
on poly-d-lysine coated, 6-well plates at the concentration
of 2 × 106 cells per well. Cells were grown for 8–10 days
(37°C, 5% CO2) and culture medium was changed every
2 days. Twenty-four hours prior to treatment with pal-
mitic acid, the medium was changed to cortical neuronal
cell culture medium.
Isolation and culture of astroglia from rat cerebellum
The enzyme digestion and trituration techniques were
performed on the cerebellum tissue from 7-day-old rat
pups, as described previously [16]. Briefly, dissected cere-
bellar tissue was placed in a cerebellar buffer solution con-
taining 136.89 mM NaCl, 5.36 mM KCl, 0.34 mM
Na2HPO4, 0.44 mM KH2PO4, 5.55 mM dextrose, 20.02
mM Hepes, and 4.17 mM NaHCO3, PH 7.4. Cerebellar
tissue was minced, transferred to 0.025% trypsin solution
in cerebellar buffer, and incubated in water bath for 15
minutes at 37°C. 0.04% DNase I solution in cerebellar
medium (DMEM supplemented with 10% horse serum,
25 mM KCl, 5 mg/ml insulin, 50 μM GABA, 100 IU/ml
penicillin, and 0.1 mg/ml streptomycine) was then added
to inactivate trypsin. After the supernatant was collected
from the trituration steps, the cells were separated from
the debris into 4% BSA solution in cerebellar buffer sup-
plemented with 0.03% MgSO4. Finally, the cells were
plated onto poly-l-lysine coated 6-well culture dishes at a
density of 2.0 × 106 cells/ml in 3 ml of fresh cerebellar
medium. After 2 days, the media was switched to DMEM/
Ham's F12 medium (1:1) to obtain pure cultures of cere-
bellar astroglia. The astroglia cell cultures with approxi-
mately 95% purity were obtained after 8–10 days culture
(37°C, 5% CO2). Twenty-four hours prior to treatment
with palmitic acid, the medium was changed to cortical
neuronal cell culture medium.
Western blot analyses
For Western blotting, cells were washed three times with
ice-cold TBS (25 mM Tris, pH 8.0, 140 mM NaCl, and 5
mM KCl) and lysed for 20 min by scraping into ice-cold
lysis buffer. To extract membrane protein BACE1, lysis
buffer containing 1% (v/v) Nonidet P-40, 0.1% (w/v)
SDS, 0.5% (w/v) deoxycholate, 50 mM Tris, pH 7.2, 150
mM NaCl, 1 mM Na3VO4 and 1 mM PMSF [all chemicals
from Sigma] was used [17]. For phosphorylated tau, lysis
buffer containing 1% (v/v) Triton, 0.1% (w/v) SDS, 0.5%
(w/v) deoxycholate, 20 mM Tris, pH 7.4, 150 mM NaCl,
100 mM NaF, 1 mM Na3VO4, 1 mM EDTA, 1 mM EGTA,
and 1 mM PMSF [all chemicals from Sigma] was used
[18]. The total cell lysate was obtained by centrifugation
at 12,000 rpm for 15 min at 4°C. The total protein con-
centration was measured by BCA protein assay kit from
Pierce (Rockford, IL, USA). Equal amounts of total protein
from each condition were run at 200 V on 10% SDS-PAGE
gels (BioRad, CA, USA). The separated proteins were
transferred to nitrocellulose membranes for 1 h at 100 V
and incubated at 4°C overnight with the appropriate pri-
mary antibodies [1:1000 BACE1 (Chemicon, CA, USA),BMC Research Notes 2008, 1:20 http://www.biomedcentral.com/1756-0500/1/20
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1:200 AT8 (Pierce Biotechnology, IL, USA), 1:2000 actin
(Sigma)]. Blots were washed three times in PBS-Tween
(PBS-T) and incubated with appropriate HRP-linked sec-
ondary antibodies (Pierce Biotechnology, IL, USA)
diluted in PBS-T for 1 h. After an additional three washes
in PBS-T, blots were developed with the Pierce SuperSig-
nal West Femto Maximum Sensitivity Substrate (Pierce
Biotechnology) and imaged with the BioRad ChemiDoc.
Data Analyses
Data are shown as means ± S.D. for three independent
experiments. Student's t-test was used to evaluate statisti-
cal significances between different treatment groups. Sta-
tistical significance was set at p < 0.05.
Results and Discussion
Previously, we showed that saturated fatty acids, palmitic
acid (PA) and stearic acid (SA), at pathological concentra-
tions (0.2 mM) have no direct effect on primary rat corti-
cal neurons [19-21]. This may be attributed to the low
capacity of primary neurons to take up and metabolize
fatty acids [22]. The astroglia, in contrast, possess a rela-
tively higher capacity to utilize fatty acids, leading to a sig-
nificant upregulation in the de novo synthesis of ceramide
when treated with saturated FFAs [21,22]. PA-induced
ceramide synthesis in cortical astroglia plays a central role
in causing tau hyperphosphorylation and BACE1 upregu-
lation in cortical neurons, possibly through secretion of
cytokines or other signaling molecules (e.g. nitric oxide)
from astroglia [21]. Tau hyperphoshorylation and
increased amyloidogenesis due to BACE1 upregulation
leads to the formation of the two most important patho-
physiological hallmarks of AD, neurofibrillary tangles and
Aβ plaques, respectively. Based on these data, which place
"astroglial FFA metabolism" at the centre of the patho-
genic cascade leading to AD, we hypothesized that differ-
ential FFA metabolism by astroglia from different brain
areas may be a deciding factor in the susceptibility of the
different brain regions; the higher the FFA metabolic activ-
ity the greater the damage and vice versa. The hypothesis
was based on the fact that the activity of fatty acyl-CoA
synthetase (FACS) is 10× lower in cerebellum (unaffected
region in AD) as compared to the other affected brain
regions [23]; FACS is the first enzyme involved in FFA
metabolism, which converts fatty acid to fatty acyl-CoA,
which is then utilized by the cells in anabolic (e.g. cera-
mide synthesis) or catabolic (e.g. β-oxidation) pathways
[24]. Thus, under pathologically elevated levels of satu-
rated FFAs, cerebellum may be less likely to be affected by
abnormal FFA metabolism due to its lower activity level of
FACS as compared to the other affected brain regions (e.g.
cortex). To test this hypothesis, we treated cortical and cer-
ebellar astroglia for 24 hours with equal concentration of
saturated fatty acid, 0.2 mM PA, or 4% bovine serum albu-
min (BSA, control) and then transferred the astroglia-con-
ditioned media to cortical neurons. After 24 hours of
treatment with astroglia-conditioned media, we checked
the levels of phosphorylated tau and BACE1 in cortical
neurons. The conditioned media from PA-treated cerebel-
lar astroglia, did not affect levels of both phosphorylated
tau and BACE1 in cortical neurons as compared to con-
trols (Figure 1). The conditioned media from PA-treated
cortical astroglia, on the other hand, induced significant
tau hyperphosphorylation and BACE1 upregulation in
cortical neurons as compared to the respective controls
(47 and 45%, respectively). These data support our
hypothesis, further emphasizing potentially causal role of
astroglial FFA metabolism in AD pathogenesis and region-
specific brain damage associated with it.
The major limitation associated with the present study
may be the use of cortical and cerebellar astroglia isolated
from different animals and by different techniques. The
well-established protocols used in our studies for the iso-
lation of rat cortical [14] and cerebellar [16] cells, required
use of rat pups of different ages. For the isolation of rat
cortical cells, embryonic [2] or very young, 1–2 day old
[14] rat pups are preferred and thus 1-day old rat pups
were used in our studies. The use of older rat pups for the
isolation of rat cortical cells significantly decreases the via-
bility and quality of the cells. On the other hand, 6–7 day
old rat pups have been widely used for the isolation of
cells from rat cerebellum [16,25]. The use of older rats for
the isolation of cerebellar cells may be attributed to the
fact that the cerebellum develops postnatally as compared
with cortex [15]. Despite these differences, both cortical
and cerebellar astroglia were allowed to proliferate and
mature under similar conditions (cultured in the same
medium for the same amount of time). Moreover, these
confluent cultures of astroglia from both the brain areas
were cultured in the same growth medium (cortical neu-
ronal medium) 24 hours prior to treatment. Also, during
the treatment period they were subjected to the same
amount of PA in the same growth medium (cortical neu-
ronal medium). Therefore, it is reasonable to compare the
results obtained with cortical and cerebellar astroglia iso-
lated from the different animals and by the different tech-
niques.
Conclusion
To our knowledge, this is the first time any of the risk fac-
tors for AD, including saturated FFAs, have been shown to
provide an experimental explanation for the region-spe-
cific damage observed in AD brain. These data warrant
further in-depth investigation of the differential FFA met-
abolic activities in cortical and cerebellar astroglia, which
may provide clues that may be translated into potential,
novel targets for therapeutic intervention in AD.BMC Research Notes 2008, 1:20 http://www.biomedcentral.com/1756-0500/1/20
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